Skip to main content
FinSpry Logo
FinSpry
CYTK logo
CYTK
(NASDAQ)
Cytokinetics, Incorporated
$66.73-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Cytokinetics, Incorporated (CYTK) Stock Price & Financial Analysis

Cytokinetics, Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$65.43 - $68.71
52-Week High$70.98
52-Week Low$29.31
Open$66.15
Volume2.47M
Average Volume (3M)2.47M
Market Cap8.17B
Shares Outstanding122.43M
Price to Sales (P/S)92.63
EV/EBITDA-12.20
Revenue (TTM)88.04M
Net Income (TTM)-784.96M
Free Cash Flow (TTM)-534.82M
EPS (TTM)$-6.41
Profit Margin-891.60%
Operating Margin-695.44%
50-Day MA$63.64
200-Day MA$54.46
52-Week Change77.63%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Cytokinetics, Incorporated

What is the current stock price for CYTK?

As of the latest trading session, CYTK stock trades at $66.73. The 52-week range is $29.31–$70.98, with a day range of $65.42–$68.71.

What is the P/E ratio for CYTK?

The P/E ratio (Price-to-Earnings) for CYTK is shown in the Key Statistics section. This valuation metric helps compare Cytokinetics, Incorporated to industry peers.

Does CYTK pay dividends?

Cytokinetics, Incorporated does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CYTK?

Based on 20 analysts, the consensus for CYTK is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CYTK?

Cytokinetics, Incorporated's market capitalization is $8.17B, classifying it as a mid-cap company. Cytokinetics, Incorporated operates in the Healthcare sector within the Biotechnology industry.